In their pan-cancer investigation of the roles of MXD3, Wu et al reported that MXD3 dysregulation was present in the majority of TCGA cancer types and that this dysregulation was associated with the progression of tumors and their prognoses. The gene discussed is MXD3; the disease is cancer.